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Abstract 
 
Microfluidic devices have been routinely used to perform multiplexed analysis at 
proteomic, genomic and cellular levels. Such analysis serves to probe fundamental 
biological questions as well as provide means for clinical diagnosis. At the proteomic and 
genomic levels, bead based assays are commonly used as solid phases to immobilize 
antigens for downstream detection. Functional cellular analysis such as proliferation 
studies use microbeads as scaffolds for cell culture. A significant majority of assay 
systems use constriction to immobilize beads while sample is flown through to utilize 
spatial-coding multiplexing strategies or divert maximal fluid flow through sensor beads. 
Spatial constriction however, results in non uniform flow of fluid across bead surface and 
substantially increases shear forces on bead surface. In a high-throughput context these 
limitations are detrimental in terms of assay reproducibility and flow rate limitation 
respectively. We demonstrate the use of a sandwiched polycarbonate membrane to trap 
microbeads in a bi-layer microfluidic chip to perform sandwiched ELISA based detection 
of murine IgG protein. Using flow-rates of 1 ml/hr we established a fluorescence limit of 
detection of 2 nanograms/ml. In order to validate the device for multimarker, we 
successfully detected EpCAM (Epithelial Cell Adhesion Marker) at concentration of 5 
nanograms/ml using flow-rates of 1 ml/hr. We also explored the usability of our device 
for single-cell analysis using MCF-7 breast cancer cells as models for proliferation 
function analysis. Anti-EpCAM coated beads were used to anchor MCF-7 cells via the 
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EpCAM receptor and serve as scaffold for cell growth. Beads in the chip supplied with 
growth media experienced viable cell growth as opposed to none of the beads with fixed 
cells. Growth was recorded for a maximum of 4 days and followed a sigmoid trend. In 
short, our study demonstrates the usability of a microfluidic chip with integrated 
membrane component to immobilize solid phase bead for proteomic biosensing and cell 
proliferation function analysis. Such assays could provide useful means to provide 
develop point-of-care diagnostic but also interrogate fundamental biologic questions in 
pathologies such as cancer.  
 
Acknowledgements 
I would like to thank my mentors, Dr. Ronald Xu and Dr. Michael Tweedle for their 
constant encouragement, access to laboratory resources and guidance whenever things 
went not according to plan. Further thanks should go to colleagues Brett Geiger for cell 
culture work and Aaron Maharry for co-designing the AutoCAD masks for lithography. 
Thanks is also due to Dr. Steve Quake and the microfluidics foundry staff for hosting me 
over the summer and providing a home to try out several ideas which made this project a 
success. This work was made possible by NCIIA grant 9872-12 OncoFilter to M.T and 
K.M. Thanks also to Shu-Wei and Keisha Milum as well as Dr. Shankaran for advice 
regarding cell biology and conjugation chemistry respectively. Thank you all. 
iii 
 
Vita 
 
 RESEARCH EXPERIENCE  
 
Microfluidic high purity analyte enrichment; Mentors: Drs. Michael Tweedle, 
Ronald Xu July 2012-Present  
 
Testing feasibility of fluidic device to enrich and filter rare proteins and plasma from 
peripheral blood  
Iterating system for device architecture optimization: multiplexing and throughput  
 
Microfluidic isolation of PBMCs and plasma from whole blood; PI: Dr. Stephen 
Quake May 2013-Present  
 
Microfluidic devices to replace Ficoll-Plaque for PBMCs and blood plasma isolation 
from infants and neonates  
 
GRANTS AND FELLOWSHIPS  
 National Collegiate Inventors and Innovators Alliance with the Lemelson 
Foundation: RFP Grant for  
 Circulating tumor cell enrichment device. Role: Lead Grant writer and Project 
Lead $25K +$50K investment 
 Pelotonia Cancer Foundation Undergraduate Fellowship: For Research in rapid 
 
 Engineering Research Fellowship: For invention of devices that mediate human 
social interactions Role: Lead gggGrant Writer and Project Lead  
 The State of Ohio-Honda Education Grant: For the establishment of course and 
teaching assistantship in teaching creativity and innovation in STEM disciplines 
Role: Lead Grant writer and Project Lead (50 students/ year).  
 
COMMERCIALIZATION ACTIVITY  
 First Place, Ohio State University Deloitte Business Plan competition 2013 and 
First Place Shark Tank, Rice University Alliance Business Plan Competition 
2013.  
 CTO, OncoFilter microfluidic genomic and proteomic enrichment chip from 
whole blood for cancer diagnostics.  
 First Undergraduate to be awarded Student Innovator of the Year Award (2013), 
Ohio State University 
iv 
 
PUBLICATIONS AND PATENTS  
 Mitra, Kinshuk, et al. "Indocyanine-green-loaded microballoons for biliary 
imaging in cholecystectomy." Journal of Biomedical Optics 17.11 (2012): 
116025-116025.  
 Mitra, Kinshuk, Christine C. Charyton, and Robert Gustafson. "A Demonstration 
of a Mastery Goal Driven Learning Environment to Foster Creativity in 
Engineering Design: Tackling the National Academy of Engineering Grand 
Challenges." PLoS One (submitted) Preprint available at SSRN (2013) on Google 
Scholar.  
 U.S Provisional Patent Nos. 61/604,714 and 61/605,981 Ohio State U. Office of 
Technology Commercialization  
 
PUBLICATIONS IN PROGRESS  
 Kinshuk Mitra, Brett C. Geiger, Ronald X. Xu, Michael F. Tweedle, “Non 
constriction based immobilization of polymer spheres for bio-sensing and 
scaffold based applications” 
Kinshuk Mitra, Gino Su, Ismail E Araci, Stephen R Quake “Soft lithography fabrication 
of trapezoid channels for microfluidic inertial PBMC separation” for Lab on a Chip 
Fields of Study 
Biomedical Engineering 
 
 
 
 
 
 
 
 
 
 
v 
 
Table of Contents 
 
Chapter 1: Introduction       1 
Chapter 2: Device Fabrication      5 
Chapter 3: Demonstration of functional capabilities of device  10 
Chapter 4: Discussion and Conclusion     15 
Chapter 5: References       19 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
vi 
 
 
 
 
 
List of Illustrations 
 
Figure 1: Simulation of shear stress profile along a constricted bead  2 
Figure 2: Importance of Single cell analysis     3 
Figure 3: A single channel of the OncoFilter device    6 
Figure 4: COMSOL simulation of flow through single channel of device 7 
Figure 5: COMSOL simulation of shear stress and velocity flow profile 8 
Figure 6: Sensor bead trapped within microfluidic channel by membrane 9 
Figure 7: Imaging of trapped bead       11 
Figure 8: Calibration curve of varying EpCAM concentrations   12 
Figure 9: Sensor beads that detect IgG and EpCAM    12 
Figure 10: Growth of cells on bead over 4 days     14 
Figure 11: Plotting the growth of a single cell in OncoFilter   14 
Figure 12: COMSOL simulation of future designs    18 
 
vii 
 
 
 
 
 
 
 
 
 
 
 
 
 
1 
 
Chapter 1: Introduction 
Microfluidic devices have traditionally played important roles in rare sample handling for 
applications such as sequencing, rare cell isolation, cell sorting and in-vitro diagnostics 
(1-3). Multimarker panel based diagnostics are especially amenable to microfluidic 
platforms as the automation dramatically increases throughput while conserving sample 
and reagent use. Systems biology approaches have delineated the importance of 
multimarker analysis in discerning pathology state and have significantly increased the 
efficacy of multimarker panels. Li et al. recently demonstrated a systems biology 
informed process of marker panel selection using multi-reaction monitoring mass 
spectrometers as instruments to select for the marker cluster with the highest positive 
predictive value (4). To implement such tests at feasible costs and viable time spans 
would require tools at the point-of-care. Bead based assays within microfluidic devices 
have been extensively reviewed with several platforms undergoing clinical testing for 
cardiovascular and cancer based pathologies (5,6). A majority of bead based systems 
utilize constriction to immobilize the solid phase bead while the mobile phase with target 
analytes is flown over (7-9). While this maximizes analyte-detector interaction and 
provides a spatial coding system for multiplexing, constriction severely hampers fluid 
flow across the bead. COMSOL simulations represented in Figure 1below highlights the 
high shear zones and radial non-uniform flow patterns created in constriction systems. 
This is primarily the result of the continuity principle as demonstrated in Equation 1 
below.  
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                                                                                                        (1) 
V: Velocity; A: Cross sectional area 
Flow introduced at 1 ml/hr along the z-axis resulted in maximal shear of 4.1379 mPa at 
constriction edges. The shear stress increases as the outlet cross-sectional area is far 
lower than that of the inlet, therefore necessitating an increase in velocity and as a result, 
shear stress. These effects can not only selectively over-saturate certain portion of the 
solid phase and hence hamper detection, but also limits the flow-rates so as to not shear 
the detection moiety off the bead. 
 
Figure 1. Simulation of shear stress profile along a sensor bead constricted to prevent 
movement of the solid phase bead. Fluid flow is along the z-axis. High shear stress 
patterns are observed at corners with no radial symmetry. Regions of beads are 
overexposed to flow while other regions receive minimal fluid contact. 
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Systems biology has also emphasized the need for a discrete understanding of biological 
systems. At the single cell level, assays probing function at levels such as genomic, 
proteomic and secretomic is proving essential for interrogating immune repertoire, drug 
discovery, effects of drugs and monitoring immunotherapy (10-13).  Functional 
proliferation assays are important in the oncology context to ascertain combination 
therapies that can overcome the clonal diversity of tumors. Rather than testing 
combination therapies on patients followed by RECIST-MRI evaluation, single cells may 
be individually assessed for resistance to drug or induced phenotypic/genotypic change 
under pharmacologic pressure. Should such functional measurements be performed via 
bulk cellular analysis, signal averaging could result in loss of information of information 
from a crucial minority sub-population. Figure 2 below highlights this challenge. Simply, 
if heterogeneous cell population (different colors) is sampled in bulk, the result only 
indicates an average representation of the population versus the single cell analysis 
platform which completely captures the diversity in the population. 
 
 
 (A) (B) 
Figure 2. In case A function measurement of heterogeneous cell (marked with different 
colored circles) at the bulk level captures an average signal without providing 
information on the level and kind of population heterogeneity. In case B single cell 
analysis provides information on both the type and level of population heterogeneity.  
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In this thesis, we outlay a device with capability to perform multimarker detection 
without constriction to retain the solid phase. We also exploit the radial uniform flow 
across the solid phase to utilize the said phase as a scaffold for single cell proliferation 
assays. We hypothesized that a bi-layer microfluidic device with a polycarbonate 
membrane in the middle can effectively trap solid phase beads for sandwich ELISA 
based quantification of biomarkers. Two independent protein analytes, murine IgG and 
human EpCAM were used on chip, producing calibration curves and to ascertain limits of 
detection. Fluorescent readout along the region of interest (solid bead) was obtained by 
pixel by pixel intensity readout to produce a score that was associated for a given 
concentration of antigen. Finally, to ascertain the capability of our microfluidic device to 
function as a micro bio-reactor, we introduced single MCF-7 breast cancer cells onto 
chip. Chips were infused with standard culture media for four days and growth was 
recorded via Live/Dead membrane dyes (Life Technologies, CA).  
The fact that both multimarker immunoassays and single cell assays can be performed on 
the same chip also lends to another important note. Multimarker immunoassays are vital 
as each marker component has a role to play at the systems level. A holistic 
comprehension of the states of the different components enables a detailed understanding 
of the state of the system and consequently state of pathology. Cells also execute function 
based on their states and function as components of a system. These two distinct 
categories of components, one at the microscale and another at the nanoscale, function 
cooperatively within both healthy and diseased tissues. Devices that can provide 
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functionalities that bridge across such wide physical scales may provide unique 
information as to the interaction of these different categories of components and their 
states in the context of such interactions. 
Chapter 2: Device Fabrication 
The microfluidic device named as the OncoFilter, uses standard soft lithography 
techniques to create microfluidic channels on Polydimethylsiloxane (PDMS). Briefly, 
transparency masks were constructed using designs constructed on AutoCAD (Autodesk 
Inc., CA). Masks were utilized to produce silicon molds using optical contact lithography 
(Stanford Microfluidics Foundy, CA). Sylgard-184 PDMS (Dow Corning, MI) was 
poured over silicon mold at a 10:1 ratio between PDMS and cross linking agent. After 
degassing, molds were baked at 70 degree Celsius in ovens for 2 hours. To bond dual 
layers of PDMS chip with the 12 micron pore polycarbonate membrane (Whatman, NJ), 
an APTES enhanced reactive oxygen plasma mediated bonding strategy was used. Aran 
et. al. detailed such a strategy previously and utilized similar device to separate plasma 
from whole blood (14). A detailed schematic of a single channel of our chip is depicted in 
Figure 3 below.  
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Figure 3. A single channel of the OncoFilter device. Multiple such channels are arrayed 
in parallel on a single device. Blue arrow indicates the direction of fluid flow.  
As can be seen from the COMSOL simulation in Figure 4, the OncoFilter bead based 
system also enables directing maximal flow of sample through the sensor bead enhancing 
contact with target analytes.  
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Figure 4. COMSOL simulation of flow through single channel of device. Fluidic flow is 
maximally through the point of overlap between two fluidic layers. Point of overlap is 
also position of the sensor bead. Flow within channel was under constant observation of 
optical microscope (Olympus, PA). Standard plastic tubing and 18 gauge needles were 
used to interface microfluidic channels with macroscopic flow systems. Luer-lock 
syringes were used as sample dispensing units with controlled release using syringe 
pump.  
COMSOL simulations were also undertaken to probe the benefit of using polycarbonate 
membranes instead of constriction. Figure 5 shows the fluidic shear stress of beads within 
channels.  
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                                   (a)                                                                         (b) 
Figure 5. COMSOL simulation of the (a) shear stress experienced by beads under a 
1ml/hr flow rate and (b) velocity flow profile. Membrane is placed directly under the 
bead and modeled using porosity information obtained from manufacturer.  
Polystyrene beads (mean 100 micron) with high polydispersity (>99%) and surface 
functionalized with strepavidin was purchased from Spherotech Inc. Beads were 
conjugated with desired antibodies, either anti-EpCAM (Abcam, MA) or anti-IgG (Sigma 
Aldrich, MO) according to manufacturers instruction. Single beads were isolated using 
micropipette and optical microscope and introduced into the microfluidic chip via the 
inlet and application of negative pressure. Figure 6 depicts a sensor bead trapped within 
the overlap region of the top and bottom flow layers in the microfluidic chip. 
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Figure 6. Sensor bead (circled in yellow) trapped within the microfluidic channel by the 
membrane. Bubbles can be removed by subjecting the system to a greater duration of 
flow and thus infusing the entire chip with fluid.  
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Chapter 3: Demonstration of functional capabilities of device 
Antigen model EpCAM and murine IgG were utilized to demonstrate microfluidic 
sandwich the ELISA on the OncoFilter. Detection was performed using fluorescence 
secondary detection antibody using FITC fluorophore for IgG and IR-800 for EpCAM 
respectively. Prior to testing, the device was infused with bovine serum albumin and 
incubated for 30 minutes. To obtain a calibration curve, antigen was diluted in 1 milliliter 
phosphate buffered saline (pH 7.4) at predetermined concentrations. Flow was introduced 
into the chip at 1ml/hr for 1 hour. Each chip housed five sensor beads, three which were 
exposed to flow and served as replicates, two which were unexposed to flow and served 
as controls. Each chip was flushed with PBS at 3ml/hr for 30 minutes. Figure 7 highlights 
the sensing capability of the OncoFilter towards a 28 kilodalton protein, EpCAM. 
EpCAM was detected using a secondary detection antibody conjugated with IR-800 CW 
dye.  
 
     (a)      (b) 
100 micron 100 micron 
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Figure 7. Imaging of the trapped bead. (a) Bead trapped over the overlap region and over 
the membrane within the chip. Bead is conjugated with anti-EpCAM. (b) After infusion 
of EpCAM and secondary anti-EpCAM conjugated with IR-800 CW, chip is imaged 
under fluorescence microscope with IR 800 filter.  
Intensity readout was performed using homebrew image analysis system. Greyscale 
images of both sides of sensor beads were obtained via fluorescent microscope. Pixel by 
pixel intensity was calculated into a cumulative fluorescence score. Maximum 
fluorescence concentration readout limit was set at 10ng/ml for EpCAM. All subsequent 
measured fluorescence was normalized to the maximum limit intensity. The calibration 
curve obtained was plotted in Figure 8 below. The curve was found to be consistent to the 
expected log-linear trend.  
 
EpCAM concentration (nanograms/ml) 
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Figure 8. Calibration curve for varying EpCAM concentrations. Curve is plotted against 
fluorescence intensity of the bead measured by CCD imaging. Intensity readings are 
normalized to the fluorescence measurement obtained at 10,000 ng/ml.   
To ensure the OncoFilter system was capable of detecting multiple markers, detection 
tests were run using murine IgG. Due to the constraint on time and the lack of need to 
validate the quantitative power of the device, calibration curve experiments were not 
performed. Qualitative comparison of FITC based detection of murine IgG to the IR-800 
based detection of EpCAM is depicted in Figure 9 below.  
 
Figure 9. Sensor beads that detects IgG using FITC (green) and EpCAM using IR-800 
(red). Both sensor beads experienced uniform radial exposure to the antigen. Antigen 
exposure was maximal at bead margins. The higher quantum yield of FITC is evidenced 
by the slight background scatter around the bead. Comparatively, the IR-800 bead enjoys 
a higher signal-to-noise ratio though IR-800 dyes enjoy significantly lower fluorescent 
quantum yields. 
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We hypothesized that because of the non-constriction based radially uniform flow, the 
OncoFilter could function as a bioprocessor. Bead based microfluidic devices generally 
make poor bioreactors as constriction leads to non-uniform flow across the bead. To 
ascertain this functionality, beads were coated with anti-EpCAM and loaded onto the 
chip. EpCAM expressing MCF-7 cells were singly separated using a micropipette and 
loaded onto the chip. In order to maintain uniform conditions, all five available channels 
of a device were loaded with single beads, either as controls with fixed cells or for 
experiment with live cells. Single MCF-7 cells were inserted until at least one attached to 
the bead. Over a period of 4 days, beads were infused with media at 10 microliter/hr and 
imaged once at 0, 24 and 96 hours. Figure 10 below depicts the fluorescent capture of the 
bead-cell culture system and Figure 11 plots the progression of cell growth over the 4 day 
period.  
 
 
 
         0hrs                      24hrs                    96hrs              Controls with 2 cells 
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Figure 10. Growth of cells on bead over the course of 4 days. Bead experienced slight 
rotation and movement during perfusion. Red cells were live and were the only ones 
counted. Control bead with 2 cells was fixed and observed no growth.  
 
Figure 11. Plotting the growth of a single cell in OncoFilter. Growth of single cell on 
bead scaffold over time followed the sigmoid trend. Fresh media was inserted into the 
dispensing tube daily.  
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Chapter 4: Discussion and Conclusion 
We investigated the capability of a membrane trapped bead based microfluidic device to 
perform proteomic sensing and cell culture. As membranes allow for non-constriction 
based capture of bead, protein detection and quantification was carried out by a modified 
sandwich ELISA protocol on-chip. In the absence of constriction, the shear stress 
experienced by the portion of the bead facing the flow and therefore under maximum 
exposure, was minimal compared to the side of the bead facing the wall of the conduit 
and therefore, constricted. This can be attributed to the navier-stokes equation under the 
case of low Reynold’s number. Under such conditions, flow follows path of least 
resistance with excess flow exiting the conduit via the membrane. This reduces fluidic 
velocity on the surface of the bead proximal to the entrance as expected from the flow 
continuity equations. In all models flow was expressed as incompressible with a no-slip 
boundary condition. The capability of such a device to perform quantitative protein 
sensing was validated by the use of human EpCAM as a model antigen. Secondary 
antibody conjugated to IR-800 dye was used as a quantitative fluorescent marker imaged 
using inverted fluorescent microscopy as can be seen in Figure 7. Calibration curve 
experiments were conducted to determine, a limit of detection and a correlation function 
between fluorescent intensity and antigen concentration produced results comparable to 
values and trends reported in literature (15, 16). We obtained a limit of detection at 10 
ng/ml for EpCAM and a log-linear calibration curve. The sample consisting of 100 ng/ml 
of murine IgG was detected using secondary antibody conjugated to FITC on chip by 
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application of protocol used to detect EpCAM. As Figure 9 demonstrated, both use of 
FITC and IR-800 was feasible and similar in the formation of a brighter fluorescent ring 
along the outline of the bead. This could potentially be due to the planar imaging of a 
spherical bead which would increase the concentration of signal around the periphery. 
We also observed sigmoid cell growth trend in Figure 11 when culturing MCF-7 cells. 
This is expected as cell doubling time decreases and cell growth reaches a point of 
saturation as competition for nutrients increases.  
A major limitation of our device as evidenced by the flow velocity simulation in Figure 
5b is the absence of contact between a bulk of our sample and the bead. While the non-
constriction strategy we employed did reduce shear stress, it also reduced opportunity for 
interaction between antigen in sample and capture antibodies on the bead. Moving 
forward, COMSOL simulations such as those in Figure 12 would guide the design of 
devices that use height to redirect flow entirely past the bead while retaining the non-
constriction principles employed in our original designs. As the simulations demonstrate, 
this would still ensure extremely low shear rates, uniform flow coverage and maximum 
juinteraction between analytes and the bead.  
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      (a) 
 
18 
 
      (b) 
 
Figure 12. COMSOL simulations of future designs (a) The shear stress on the bead is 
much better radially distributed through the use of a cylindrical cavity (b) The flow 
velocity simulation demonstrates that the bead is maximally exposed to the sample.  
In conclusion, our experiments demonstrate the advantages of using a non-constriction 
type immobilized bead-based assay to perform immunoassays under lower shear stress 
and with better fluidic distribution around the bead. We characterize and demonstrate a 
functional model capable of performing quantitative sandwich ELISA as well as serve as 
a micro-bioreactor. Future experiments will build on our proof of principle to construct 
chips where the bead is placed directly in the path of a straight fluid flow ensuring 
maximal exposure to sample.  
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